Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

TGF-β Pathway Inhibition Improves Hematopoietic Deficiency and Immune Imbalance By Repairing Endothelial Progenitor Cell Function in Aplastic Anemia

Xinyan Zhang, Li-Ping Guo, Jin-Song Jia, Ya-Zhe Wang, Mi Liang, Mengzhu Shen, Zhenkun Wang, Chen-Yuan Li, Zhong-Shi Lyu, Tong Xing, Zhi-Wei Zhang, Yuan-Yuan Zhang, Xiao-Jun Huang, Yuan Kong

Blood (2024) 144 (Supplement 1): 4074.

https://doi.org/10.1182/blood-2024-201438

Published: 2024

Journal Articles

Mechanism of Hyperactive PLCγ1 Signaling in T-Cell Leukemia/Lymphoma

Longhui Zeng, Xinyan Zhang, Yiwei Xiong, Nicole Hajicek, John Sondek, Xiaolei Su

Blood (2024) 144 (Supplement 1): 48.

https://doi.org/10.1182/blood-2024-193065

Published: 2024

Journal Articles

Sustained Improvements in Patient-Reported Quality of Life up to 24 Months Post-Treatment with LentiGlobin for Sickle Cell Disease (bb1111) Gene Therapy

Mark C. Walters, John F. Tisdale, Markus Y. Mapara, Lakshmanan Krishnamurti, Janet L. Kwiatkowski, Banu Aygun, Kimberly A. Kasow, Stacey Rifkin-Zenenberg, Jennifer Jaroscak, Diana Garbinsky, Costel Chirila, Meghan E. Gallagher, Xinyan Zhang, Pei-Ran Ho, Alexis A. Thompson, Julie Kanter

Blood (2021) 138 (Supplement 1): 7.

https://doi.org/10.1182/blood-2021-146905

Published: 2021

Journal Articles

Polyclonality Strongly Correlates with Biological Outcomes and Is Significantly Increased Following Improvements to the Phase 1/2 HGB-206 Protocol and Manufacturing of LentiGlobin for Sickle Cell Disease (SCD; bb1111) Gene Therapy (GT)

Blood (2021) 138 (Supplement 1): 561.

https://doi.org/10.1182/blood-2021-147760

Published: 2021